miRNA-31-5p在过量维甲酸抑制C2C12细胞增殖中的调控机制研究  

Regulatory mechanisms of miRNA- 31- 5p in excess retinoic acid- induced abnormal C2C12 cell proliferation

作　　者：唐燚[1] 刘波[1] 李楠[1] 丛蔚[1] 肖晶[1] 

机构地区：[1]大连医科大学口腔医学院口腔基础教研室,辽宁大连116044

出　　处：《大连医科大学学报》2016年第1期6-11,共6页Journal of Dalian Medical University

基　　金：国家自然科学基金项目(81271120;815709627);教育部博士学科专项基金项目(20132105110001);辽宁省博士科研启动基金项目(20141117)

摘　　要：目的探讨miRNA-31-5p在过量维甲酸(Retinoic acid,RA)抑制小鼠肌原细胞系C2C12增殖中的作用机制。方法在10μmol/L RA及无RA条件下,q PCR检测C2C12细胞增殖过程中miRNA-31-5p及抗肌营养不良蛋白(dystrophine,Dmd)表达的水平;分别转染miRNA-31-5p mimics(miRNA-31-5p mimics组)、miRNA-31-5p inhibitor(miRNA-31-5p inhibitor组)、Duplex N.C(Duplex N.C组)及N.C inhibitor(N.C inhibitor组)。用细胞增殖/毒性检测实验(CCK-8)检测0 h,24 h,36 h及48 h的OD值,5-溴脱氧尿嘧啶核苷掺入实验(Brd U)检测48 h细胞中Brd U阳性细胞比率。在10μmol/L RA条件下,q PCR检测C2C12细胞在下调miRNA-31-5p后,Dmd表达水平变化。结果在10μmol/L RA条件下,细胞中miRNA-31-5p在36 h及48 h的表达水平均明显高于相同时间点正常条件下的表达水平,P<0.01;Dmd在36 h及48 h的表达水平均明显低于相同时间点正常条件下的表达水平,P<0.01。CCK-8结果显示在0μmol/L RA条件下,miRNA-31-5p过表达抑制C2C12细胞增殖,10μmol/L RA条件下,细胞的增殖活性进一步降低;0μmol/L RA条件下,miRNA-31-5p低表达促进C2C12细胞增殖,10μmol/L RA作用下,miRNA-31-5p inhibitor组细胞增殖活性在第48 h显著高于N.C inhibitor组,P<0.01。10μmol/L RA的作用下,miRNA-31-5p mimics组细胞Brd U阳性率与Duplex N.C组比降低27.6%,P<0.05;miRNA-31-5p inhibitor组细胞Brd U阳性率与N.C inhibitor组相比升高24.1%,P<0.05。转染48 h后,miRNA-31-5p inhibitor组Dmd的相对表达量较N.C inhibitor组明显上调,P<0.01;在10μmol/L RA作用下,miRNA-31-5p inhibitor组细胞Dmd的表达升高,与N.C inhibitor组相比差异具有显著性意义。结论 miRNA-31-5p可参与10μmol/L RA导致的C2C12细胞增殖抑制,而其可能的分子机制是通过对Dmd靶向作用实现的。Objective To investigate miRNA- 31- 5p regulation mechanism in decreased proliferation of C2C12 myoblast cell line which was caused by excess retinoic acid（ RA）. Methods Establish proliferation assay model of C2C12 cell lines in vitro. The expression level of miRNA- 31- 5p and dystrophine（ Dmd） in C2C12 cells without RA or added with 10 μmol / L RA were detected using q PCR. Liposome of the miRNA- 31- 5p analogues（ miRNA- 31- 5p mimics） or inhibitors（ miRNA- 31- 5p inhibitor） were transfected into C2C12 cells,with the corresponding load（ Duplex N. C or N. C inhibitor） measured as the control group. The absorbance value（ OD index） of cells was monitored by cell proliferation / cytotoxicity detection reagent（ Cell Counting Kit- 8,CCK- 8） in 0 h,24 h,36 h and 48 h. Using 5- bromodeoxyuridine incorporation assay（ Brd U assay）,Brd U- positive cells rate in 48 h was detected. After miRNA- 31- 5p was down- regulated,the expression level of Dmd was analyzed by q PCR under the condition of10 μmol / L RA. Results In the state of 10 μmol / L RA,expression levels of miRNA- 31- 5p had an increase tendency in 36 h and 48 h（ P〈 0. 01）,and 10 μmol / L RA inhibited the expression of Dmd,with the significant differences in 36 h and 48 h（ P〈0. 01）. CCK- 8 showed that miRNA- 31- 5p inhibitor was shown to reduce C2C12 cells proliferation activity,which was also suppressed by 10 μmol / L RA to a lower degree. In contrast,down- regulation of miRNA- 31- 5p significantly promoted cell proliferation（ P 〈0. 01）. miRNA- 31- 5p inhibitor was shown to promote proliferation of C2C12 cells at 48 h comparing to N. C inhibitor under the stimulation of 10 μmol / L RA. Under the effect of 10 μmol / L RA,Brd U- positive cells rate of miRNA- 31- 5p mimics group was 27. 6% lower than Duplex N. C group（ P 〈0. 05）,and Brd U- positive cells rate of miRNA- 31- 5p inhibitor group was elevated by 24. 1%compared to N. C inhibitor group（ P 〈0. 05）. After 48 h of miRNA- 31- 5p inhibitor trans

关 键 词：miRNA-31-5p 维甲酸 C2C12细胞 细胞增殖 

分 类 号：R965[医药卫生—药理学]